Related Experiment Videos
Inadequate cortisol synthesis in prophyria cutanea tarda
D Pereţianu1, D Sava, C Giurcăneanu
1Department of Endocrinology and Applied Immunology, Hospital St. John, Bucharest, Romania.
Endocrinologie
|January 1, 1991
Summary
Cortisol secretion may be impaired in patients with porphyria cutanea tarda (PCT), potentially due to porphyrin accumulation affecting adrenal function. This suggests a link between PCT and corticosuprarenal insufficiency (CSRI).
Area of Science:
- Endocrinology
- Metabolic Disorders
- Toxicology
Background:
- Clinical similarities between corticosuprarenal insufficiency (CSRI) and porphyria cutanea tarda (PCT) suggest potential pathogenic links.
- Understanding the relationship between PCT and adrenal function is crucial for comprehensive patient management.
Purpose of the Study:
- To investigate the adrenal response to ACTH stimulation in patients with PCT.
- To explore potential functional impairments in cortisol secretion in PCT patients.
Main Methods:
- Administered ACTH-depot stimulation test (1 mg, i.m.) to 13 male patients with PCT.
- Assayed cortisol metabolite (17-OH-corticosteroids) levels at baseline and 1, 2, 12, and 24 hours post-stimulation in 8 patients.
- Compared patient results to normal limits and control group data.
Main Results:
- All 13 PCT patients exhibited basal 17-OH-corticosteroid eliminations below normal limits.
- Four patients showed a lack of cortisol stimulation post-ACTH.
- Two patients displayed impaired early cortisol stimulation with elevated late levels, suggesting functional cortisol secretion deficits possibly linked to receptor lesions.
Conclusions:
- PCT patients may have impaired cortisol secretion, potentially due to porphyrin accumulation affecting adrenal function.
- Findings suggest a functional relationship between PCT and CSRI, possibly involving mitochondrial porphyrin receptor activity.
- Further research into porphyrin-induced adrenal dysfunction in PCT is warranted.